Effects of mannitol on the acute lung injury induced by oleic acid in rats.
Our purpose was to evaluate the pulmonary effects of mannitol infusion in a rat model of acute lung injury induced by oleic acid (OA) to compare the effects of mannitol to those of another diuretic, furosemide (FUR), and to assess if mannitol effects remained after correction of the volume depletion induced by this agent. Acute lung injury was induced in Wistar rats by intravenous administration of 100 mg/kg of OA. Mannitol (1 mL of a 20% solution) was infused either 15 min before or 2 h after OA infusion. FUR was infused intravenously in a dose (1 mg/kg) that induced a similar amount of diuresis compared to mannitol. We also studied rats that received NaCl 0.9% infusion to correct for volume losses induced by mannitol. The severity of the acute lung injury was evaluated by morphometric studies of the lungs 4 h after OA infusion. The amount of intraalveolar fluid accumulation and the intensity of alveolar distention and collapse were evaluated. Mannitol infusion either 15 min before or 2 h after OA administration resulted in a significant decrease in the amount of intraalveolar edema and alveolar distention and collapse (P < 0.001). FUR administration before OA infusion had an effect similar to mannitol. We did not observe any significant effect of mannitol when the rats received saline infusion to correct for diuresis induced by mannitol. We conclude that mannitol decreases the severity of pulmonary injury induced by OA in rats. This effect is mainly due to its diuretic properties.
Hilkner-Silva
M
M
Department of Medicine, School of Medicine, University of Sao Paulo, Brazil.
Leme
A S
AS
Arantes-Costa
F M
FM
Saldiva
P H
PH
Lichtenstein
A
A
Martins
M A
MA
D000818:Animals; D004232:Diuretics / Q000008:administration & dosage / Q000494:pharmacology; D004234:Diuretics, Osmotic / Q000008:administration & dosage / Q000494:pharmacology; D005665:Furosemide / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D006982:Hypertonic Solutions; D007262:Infusions, Intravenous; D008168:Lung / Q000187:drug effects* / Q000473:pathology; D055370:Lung Injury; D008297:Male; D008353:Mannitol / Q000008:administration & dosage / Q000494:pharmacology*; D019301:Oleic Acid / Q000633:toxicity*; D011654:Pulmonary Edema / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D012128:Respiratory Distress Syndrome / Q000188:drug therapy
D004232:Diuretics; D004234:Diuretics, Osmotic; D006982:Hypertonic Solutions; D019301:Oleic Acid; D008353:Mannitol; D005665:Furosemide